AstraZeneca Pharmaceuticals LP
Registered Principal Details
Business Or Interest:
Research, development and sales of pharmaceuticals
Lobbying Interests:
All matters pertaining to the researching, development marketing, sale and distribution of medications.
CEO Name:
David Brennen
Executive Director
Research, development and sales of pharmaceuticals
Lobbying Interests:
All matters pertaining to the researching, development marketing, sale and distribution of medications.
CEO Name:
David Brennen
Executive Director
Contact
JK
Jacqueline Kirby
PO Box 15437
Wilmington, DE 19850-5737
(302) 885-5412
(302) 885-1110
jacqueline.kirby@astrazeneca.com
http://www.astrazeneca.com
PO Box 15437
Wilmington, DE 19850-5737
(302) 885-5412
(302) 885-1110
jacqueline.kirby@astrazeneca.com
http://www.astrazeneca.com
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|
Lobbying Interests
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs
Health Services: Medical Assistance and Related Programs
Notification Date
2/8/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/8/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Regulation and Licensing
Regulation and Licensing
Notification Date
4/14/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
the proposed expansion of the Pharmacy Scope of Practice
4/14/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Comments
the proposed expansion of the Pharmacy Scope of Practice
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Combined Reporting
Combined Reporting
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicaid
Medicaid
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicaid
Medicaid
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicare
Medicare
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicare
Medicare
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Phamaceutical Companies
Phamaceutical Companies
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmaceutical Companies
Pharmaceutical Companies
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Prescriber Data
Prescriber Data
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2011 January - June $32,688.92 |
2011 July - December $26,288.63 |
2012 January - June $19,745.77 |
2012 July - December $316.89 |
Total $79,040.20 |
Total Hours Communicating | 2011 January - June 43.00 |
2011 July - December 17.00 |
2012 January - June 8.50 |
2012 July - December 0.00 |
Total 68.50 |
Total Hours Other | 2011 January - June 63.50 |
2011 July - December 24.50 |
2012 January - June 25.00 |
2012 July - December 6.00 |
Total 119.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 50% |
2011 July - December 50% |
2012 January - June 25% |
2012 July - December 25% |
Total 45% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June 50% |
2011 July - December 50% |
2012 January - June 75% |
2012 July - December 75% |
Total 55% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.